Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors

INTRODUCTION: Azacitidine (AZA) either single-agent or with donor lymphocytes infusions (DLI) has been used as a salvage treatment for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) relapsing after allogeneic hematopoietic stem cell transplantation (HSCT). To date, the majority of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberatore, Carmine, Stanghellini, Maria Teresa Lupo, Lorentino, Francesca, Vago, Luca, Carrabba, Matteo Giovanni, Greco, Raffaella, Marktel, Sarah, Assanelli, Andrea, Farina, Francesca, Corti, Consuelo, Bernardi, Massimo, Peccatori, Jacopo, Sockel, Katja, Middeke, Jan Moritz, Schetelig, Johannes, Bergmann, Anika, Rautenberg, Christina, Ciceri, Fabio, Bornhäuser, Martin, Schroeder, Thomas, Stölzel, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210096/
https://www.ncbi.nlm.nih.gov/pubmed/35747461
http://dx.doi.org/10.1177/20406207221090882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210096/
https://www.ncbi.nlm.nih.gov/pubmed/35747461
http://dx.doi.org/10.1177/20406207221090882

Ejemplares similares